Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2128543rdf:typepubmed:Citationlld:pubmed
pubmed-article:2128543lifeskim:mentionsumls-concept:C0035298lld:lifeskim
pubmed-article:2128543lifeskim:mentionsumls-concept:C0031638lld:lifeskim
pubmed-article:2128543lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2128543lifeskim:mentionsumls-concept:C0021431lld:lifeskim
pubmed-article:2128543lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:2128543lifeskim:mentionsumls-concept:C0596837lld:lifeskim
pubmed-article:2128543pubmed:issue4lld:pubmed
pubmed-article:2128543pubmed:dateCreated1991-5-28lld:pubmed
pubmed-article:2128543pubmed:abstractTextVisible light changes IR light scatter through a toad retina. This signal presents three components: at low light intensity (100-400 bleached rhodopsins/rod) an early decrease in IR light scatter, of small amplitude, with time to peak of 1-6 s; at intermediate light intensity (1200-16,000 bleached rhodopsins/rod) a slow increase in IR light scatter, with time to peak of 10-30 s; at high light intensity (50,000-160,000 bleached rhodopsins/rod) a last increase in IR light scatter, with time to peak of 1 min. Light sensitivity, amplitude and time to peak of the last two components are increased by inhibitors (3-isobutyl-1-methyl-xanthine and papaverine) of the cyclic 3'5' guanosine monophosphate phosphodiesterase.lld:pubmed
pubmed-article:2128543pubmed:languageenglld:pubmed
pubmed-article:2128543pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2128543pubmed:citationSubsetIMlld:pubmed
pubmed-article:2128543pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2128543pubmed:statusMEDLINElld:pubmed
pubmed-article:2128543pubmed:monthOctlld:pubmed
pubmed-article:2128543pubmed:issn0031-8655lld:pubmed
pubmed-article:2128543pubmed:authorpubmed-author:SteinP JPJlld:pubmed
pubmed-article:2128543pubmed:authorpubmed-author:CarettaAAlld:pubmed
pubmed-article:2128543pubmed:issnTypePrintlld:pubmed
pubmed-article:2128543pubmed:volume52lld:pubmed
pubmed-article:2128543pubmed:ownerNLMlld:pubmed
pubmed-article:2128543pubmed:authorsCompleteYlld:pubmed
pubmed-article:2128543pubmed:pagination839-43lld:pubmed
pubmed-article:2128543pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:2128543pubmed:meshHeadingpubmed-meshheading:2128543-...lld:pubmed
pubmed-article:2128543pubmed:meshHeadingpubmed-meshheading:2128543-...lld:pubmed
pubmed-article:2128543pubmed:meshHeadingpubmed-meshheading:2128543-...lld:pubmed
pubmed-article:2128543pubmed:meshHeadingpubmed-meshheading:2128543-...lld:pubmed
pubmed-article:2128543pubmed:meshHeadingpubmed-meshheading:2128543-...lld:pubmed
pubmed-article:2128543pubmed:meshHeadingpubmed-meshheading:2128543-...lld:pubmed
pubmed-article:2128543pubmed:meshHeadingpubmed-meshheading:2128543-...lld:pubmed
pubmed-article:2128543pubmed:meshHeadingpubmed-meshheading:2128543-...lld:pubmed
pubmed-article:2128543pubmed:year1990lld:pubmed
pubmed-article:2128543pubmed:articleTitleLight-induced infrared light scattering signal in the retina: effect of phosphodiesterase inhibitors.lld:pubmed
pubmed-article:2128543pubmed:affiliationDepartment of Ophthalmology and Visual Science, Yale University Medical School, New Haven, CT 06510.lld:pubmed
pubmed-article:2128543pubmed:publicationTypeJournal Articlelld:pubmed